Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3079764rdf:typepubmed:Citationlld:pubmed
pubmed-article:3079764lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3079764lifeskim:mentionsumls-concept:C0608437lld:lifeskim
pubmed-article:3079764lifeskim:mentionsumls-concept:C0023884lld:lifeskim
pubmed-article:3079764lifeskim:mentionsumls-concept:C0683140lld:lifeskim
pubmed-article:3079764lifeskim:mentionsumls-concept:C0010762lld:lifeskim
pubmed-article:3079764lifeskim:mentionsumls-concept:C0443286lld:lifeskim
pubmed-article:3079764lifeskim:mentionsumls-concept:C0032529lld:lifeskim
pubmed-article:3079764lifeskim:mentionsumls-concept:C1979928lld:lifeskim
pubmed-article:3079764lifeskim:mentionsumls-concept:C0376315lld:lifeskim
pubmed-article:3079764lifeskim:mentionsumls-concept:C0311404lld:lifeskim
pubmed-article:3079764lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:3079764lifeskim:mentionsumls-concept:C1998793lld:lifeskim
pubmed-article:3079764lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:3079764lifeskim:mentionsumls-concept:C2348205lld:lifeskim
pubmed-article:3079764pubmed:issue2lld:pubmed
pubmed-article:3079764pubmed:dateCreated1986-2-14lld:pubmed
pubmed-article:3079764pubmed:abstractTextTwo forms of cytochrome P-450 (P-450), designated P-450MP-1 and P-450MP-2, were purified to electrophoretic homogeneity from human liver microsomes on the basis of mephenytoin 4-hydroxylase activity. Purified P-450MP-1 and P-450MP-2 contained 12-17 nmol of P-450/mg of protein and had apparent monomeric molecular weights of 48,000 and 50,000, respectively. P-450MP-1 and P-450MP-2 were found to be very similar proteins as judged by chromatographic behavior on n-octylamino-Sepharose 4B, hydroxylapatite, and DEAE- and CM-cellulose columns, spectral properties, amino acid composition, peptide mapping, double immunodiffusion analysis, immunoinhibition, and N-terminal amino acid sequences. In vitro translation of liver RNA yielded polypeptides migrating with P-450MP-1 or P-450MP-2, depending upon which form was in each sample, indicating that the two P-450s are translated from different mRNAs. When reconsituted with NADPH-cytochrome-P-450 reductase and L-alpha-dilauroyl-sn-glyceryo-3-phosphocholine, P-450MP-1 and P-450MP-2 gave apparently higher turnover numbers for mephenytoin 4-hydroxylation than did the P-450 in the microsomes. The addition of purified rat or human cytochrome b5 to the reconstituted system caused a significant increase in the hydroxylation activity; the maximum stimulation was obtained when the molar ratio of cytochrome b5 to P-450 was 3-fold. Rabbit anti-human cytochrome b5 inhibited NADH-cytochrome-c reductase and S-mephenytoin 4-hydroxylase activities in human liver microsomes. In the presence of cytochrome b5, the Km value for S-mephenytoin was 1.25 mM with all five purified cytochrome P-450s preparations, and Vmax values were 0.8-1.25 nmol of 4-hydroxy product formed per min/nmol of P-450. P-450MP is a relatively selective P-450 form that metabolizes substituted hydantoins well. Reactions catalyzed by purified P-450MP-1 and P-450MP-2 preparations and inhibited by anti-P-450MP in human liver microsomes include S-mephenytoin 4-hydroxylation, S-nirvanol 4-hydroxylation, S-mephenytoin N-demethylation, and diphenylhydantoin 4-hydroxylation. Thus, at least two very similar forms of human P-450 are involved in S-mephenytoin 4-hydroxylation, an activity which shows genetic polymorphism.lld:pubmed
pubmed-article:3079764pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3079764pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3079764pubmed:languageenglld:pubmed
pubmed-article:3079764pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3079764pubmed:citationSubsetIMlld:pubmed
pubmed-article:3079764pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3079764pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3079764pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3079764pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3079764pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3079764pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3079764pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3079764pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3079764pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3079764pubmed:statusMEDLINElld:pubmed
pubmed-article:3079764pubmed:monthJanlld:pubmed
pubmed-article:3079764pubmed:issn0021-9258lld:pubmed
pubmed-article:3079764pubmed:authorpubmed-author:ShimadaTTlld:pubmed
pubmed-article:3079764pubmed:authorpubmed-author:GuengerichF...lld:pubmed
pubmed-article:3079764pubmed:authorpubmed-author:MisonoK SKSlld:pubmed
pubmed-article:3079764pubmed:issnTypePrintlld:pubmed
pubmed-article:3079764pubmed:day15lld:pubmed
pubmed-article:3079764pubmed:volume261lld:pubmed
pubmed-article:3079764pubmed:ownerNLMlld:pubmed
pubmed-article:3079764pubmed:authorsCompleteYlld:pubmed
pubmed-article:3079764pubmed:pagination909-21lld:pubmed
pubmed-article:3079764pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3079764pubmed:meshHeadingpubmed-meshheading:3079764-...lld:pubmed
pubmed-article:3079764pubmed:meshHeadingpubmed-meshheading:3079764-...lld:pubmed
pubmed-article:3079764pubmed:meshHeadingpubmed-meshheading:3079764-...lld:pubmed
pubmed-article:3079764pubmed:meshHeadingpubmed-meshheading:3079764-...lld:pubmed
pubmed-article:3079764pubmed:meshHeadingpubmed-meshheading:3079764-...lld:pubmed
pubmed-article:3079764pubmed:meshHeadingpubmed-meshheading:3079764-...lld:pubmed
pubmed-article:3079764pubmed:meshHeadingpubmed-meshheading:3079764-...lld:pubmed
pubmed-article:3079764pubmed:meshHeadingpubmed-meshheading:3079764-...lld:pubmed
pubmed-article:3079764pubmed:meshHeadingpubmed-meshheading:3079764-...lld:pubmed
pubmed-article:3079764pubmed:meshHeadingpubmed-meshheading:3079764-...lld:pubmed
pubmed-article:3079764pubmed:meshHeadingpubmed-meshheading:3079764-...lld:pubmed
pubmed-article:3079764pubmed:meshHeadingpubmed-meshheading:3079764-...lld:pubmed
pubmed-article:3079764pubmed:meshHeadingpubmed-meshheading:3079764-...lld:pubmed
pubmed-article:3079764pubmed:meshHeadingpubmed-meshheading:3079764-...lld:pubmed
pubmed-article:3079764pubmed:meshHeadingpubmed-meshheading:3079764-...lld:pubmed
pubmed-article:3079764pubmed:meshHeadingpubmed-meshheading:3079764-...lld:pubmed
pubmed-article:3079764pubmed:meshHeadingpubmed-meshheading:3079764-...lld:pubmed
pubmed-article:3079764pubmed:meshHeadingpubmed-meshheading:3079764-...lld:pubmed
pubmed-article:3079764pubmed:meshHeadingpubmed-meshheading:3079764-...lld:pubmed
pubmed-article:3079764pubmed:meshHeadingpubmed-meshheading:3079764-...lld:pubmed
pubmed-article:3079764pubmed:meshHeadingpubmed-meshheading:3079764-...lld:pubmed
pubmed-article:3079764pubmed:meshHeadingpubmed-meshheading:3079764-...lld:pubmed
pubmed-article:3079764pubmed:year1986lld:pubmed
pubmed-article:3079764pubmed:articleTitleHuman liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction.lld:pubmed
pubmed-article:3079764pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3079764pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3079764pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:1559entrezgene:pubmedpubmed-article:3079764lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3079764lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3079764lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3079764lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3079764lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3079764lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3079764lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3079764lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3079764lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3079764lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3079764lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3079764lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3079764lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3079764lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3079764lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3079764lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3079764lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3079764lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3079764lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3079764lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3079764lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3079764lld:pubmed